Physiomics (GB:PYC) has released an update.
Physiomics PLC, a leader in mathematical modelling for therapeutic development, reported a record £1.1 million in new contracts for the fiscal year ending June 2024, with over £500k in contracted revenue carried into the next year. Despite these contract wins, the company experienced a 6% drop in total income and an increased operating loss of 17%. The company also completed a strategic repositioning that includes a management reshuffle and the introduction of new services in biostatistics and personalized dosing software.
For further insights into GB:PYC stock, check out TipRanks’ Stock Analysis page.
